ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)

$4.22 0.11 (2.6764%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 71

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) News Sources

Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy

15-04-2026

yahoo.com

Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting

16-04-2026

yahoo.com

Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors

17-04-2026

yahoo.com

Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology

22-04-2026

yahoo.com

Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy

27-04-2026

yahoo.com

Alterity Therapeutics Releases Appendix 4C – Q3 FY26 Quarterly Cash Flow Report & Corporate Update

30-04-2026

yahoo.com

Alterity Therapeutics to Deliver Presentations at Multiple Medical Conferences in May 2026

07-05-2026

yahoo.com

Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy

11-05-2026

yahoo.com

Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy

19-05-2026

yahoo.com

Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy

09-06-2026

yahoo.com

ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) Sentiment Trend

0 25 50 75 100 77 77 69 65 68 61 77 68 77 75 15-04-2026 16-04-2026 17-04-2026 22-04-2026 27-04-2026 30-04-2026 07-05-2026 11-05-2026 19-05-2026 09-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) FAQs

toggle

What is the current price of ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)?

The current price of ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) is $4.22.


toggle

ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) absolute price change since previous trading day?

The absolute price change of ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) since the previous trading day is $0.11.


toggle

ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) percentage price change since previous trading day?

The percentage price change of ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) since the previous trading day is 2.6764%.


toggle

What is the most recent average sentiment score for ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)?

The most recent average sentiment score for ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) is 71 out of 100.


toggle

What is the most recent average sentiment for ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)?

The most recent sentiment for ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) is .


SEC-8K** Filing Available For ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.